Financial Advisors Network’s Pfizer PFE Stock Holding History

Financial Advisors Network’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,056	Closed	-$31.4K	–	363
2016 Q4	$31.4K	Buy	+1,056	New	+$32.2K	0.03%	161

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Financial Advisors Network's PFE Position: Q1 2017 in Review

Financial Advisors Network sold out of Pfizer (PFE) in Q1 2017, closing a stake of 1,056 shares — an estimated $31.4K sold.

Financial Advisors Network first reported a position in PFE in Q4 2016 and held it in 1 quarter. The position peaked at $31.4K in Q4 2016. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Financial Advisors Network reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
Financial Advisors Network sold 1,056 Pfizer shares in Q1 2017, an estimated $31.4K.
Financial Advisors Network first reported a position in Pfizer in Q4 2016 and held it in 1 quarter.
Financial Advisors Network's Pfizer position peaked at $31.4K in Q4 2016.
2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Financial Advisors Network's 13F filing for Q1 2017, filed 17 May 2017.